FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917729279> ?p ?o ?g. }

• W2917729279 abstract "The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to tumour necrosis factor inhibitor (TNFi) therapy in axial spondyloarthritis (axSpA) patients. Prospective observational study during 1 year with 2 cohorts (Madrid and Amsterdam) including 180 axSpA patients treated with standard doses of infliximab or adalimumab. Patients were stratified by BMI, being 78 (43%) normal weight (18.5–24.9 kg/m2) and 102 (57%) overweight/obese (≥ 25.0 kg/m2). After the first year of treatment, TNFi trough levels were measured by capture ELISA. Clinical response to TNFi was defined as ∆BASDAI ≥ 2 and clinical remission as BASDAI < 2 and CRP ≤ 5 mg/L. Logistic regression models were employed to analyse the association between concomitant csDMARDs and BMI with drug levels and clinical response. Seventy-nine patients (44%) received concomitant csDMARDs. The administration of concomitant csDMARDs (OR 3.82; 95% CI 1.06–13.84) and being normal weight (OR 18.38; 95% CI 2.24–150.63) were independently associated with serum TNFi drug persistence. Additionally, the use of concomitant csDMARDs contributed positively to achieve clinical response (OR 7.86; 95% CI 2.39–25.78) and remission (OR 4.84; 95% CI 1.09–21.36) in overweight/obese patients, but no association was found for normal-weight patients (OR 1.10; 0.33–3.58). The use of concomitant csDMARDs with TNFi may increase the probability of achieving clinical response in overweight/obese axSpA patients. Further research studies including larger cohorts of patients need to be done to confirm it." @default.
• W2917729279 created "2019-03-02" @default.
• W2917729279 creator A5005771375 @default.
• W2917729279 creator A5014085631 @default.
• W2917729279 creator A5029733252 @default.
• W2917729279 creator A5050087953 @default.
• W2917729279 creator A5050984986 @default.
• W2917729279 creator A5053902058 @default.
• W2917729279 creator A5054608926 @default.
• W2917729279 creator A5056993203 @default.
• W2917729279 creator A5058087062 @default.
• W2917729279 creator A5069156323 @default.
• W2917729279 creator A5072690427 @default.
• W2917729279 date "2019-02-20" @default.
• W2917729279 modified "2023-10-18" @default.
• W2917729279 title "Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis" @default.
• W2917729279 cites W1853566650 @default.
• W2917729279 cites W2008771268 @default.
• W2917729279 cites W2019754024 @default.
• W2917729279 cites W2020589546 @default.
• W2917729279 cites W2095161324 @default.
• W2917729279 cites W2096545621 @default.
• W2917729279 cites W2111046066 @default.
• W2917729279 cites W2122404129 @default.
• W2917729279 cites W2125389744 @default.
• W2917729279 cites W2133606090 @default.
• W2917729279 cites W2156605473 @default.
• W2917729279 cites W2171249245 @default.
• W2917729279 cites W2293697732 @default.
• W2917729279 cites W2434777093 @default.
• W2917729279 cites W2544657334 @default.
• W2917729279 cites W2572897530 @default.
• W2917729279 cites W2589117680 @default.
• W2917729279 cites W2738341831 @default.
• W2917729279 cites W2789967293 @default.
• W2917729279 doi "https://doi.org/10.1186/s13075-019-1849-3" @default.
• W2917729279 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6383284" @default.
• W2917729279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30786913" @default.
• W2917729279 hasPublicationYear "2019" @default.
• W2917729279 type Work @default.
• W2917729279 sameAs 2917729279 @default.
• W2917729279 citedByCount "9" @default.
• W2917729279 countsByYear W29177292792020 @default.
• W2917729279 countsByYear W29177292792021 @default.
• W2917729279 countsByYear W29177292792022 @default.
• W2917729279 countsByYear W29177292792023 @default.
• W2917729279 crossrefType "journal-article" @default.
• W2917729279 hasAuthorship W2917729279A5005771375 @default.
• W2917729279 hasAuthorship W2917729279A5014085631 @default.
• W2917729279 hasAuthorship W2917729279A5029733252 @default.
• W2917729279 hasAuthorship W2917729279A5050087953 @default.
• W2917729279 hasAuthorship W2917729279A5050984986 @default.
• W2917729279 hasAuthorship W2917729279A5053902058 @default.
• W2917729279 hasAuthorship W2917729279A5054608926 @default.
• W2917729279 hasAuthorship W2917729279A5056993203 @default.
• W2917729279 hasAuthorship W2917729279A5058087062 @default.
• W2917729279 hasAuthorship W2917729279A5069156323 @default.
• W2917729279 hasAuthorship W2917729279A5072690427 @default.
• W2917729279 hasBestOaLocation W29177292791 @default.
• W2917729279 hasConcept C126322002 @default.
• W2917729279 hasConcept C17991360 @default.
• W2917729279 hasConcept C198451711 @default.
• W2917729279 hasConcept C2776260265 @default.
• W2917729279 hasConcept C2777138892 @default.
• W2917729279 hasConcept C2777226972 @default.
• W2917729279 hasConcept C2777453003 @default.
• W2917729279 hasConcept C2777575956 @default.
• W2917729279 hasConcept C2779384505 @default.
• W2917729279 hasConcept C2780132546 @default.
• W2917729279 hasConcept C2780221984 @default.
• W2917729279 hasConcept C2780586474 @default.
• W2917729279 hasConcept C71924100 @default.
• W2917729279 hasConceptScore W2917729279C126322002 @default.
• W2917729279 hasConceptScore W2917729279C17991360 @default.
• W2917729279 hasConceptScore W2917729279C198451711 @default.
• W2917729279 hasConceptScore W2917729279C2776260265 @default.
• W2917729279 hasConceptScore W2917729279C2777138892 @default.
• W2917729279 hasConceptScore W2917729279C2777226972 @default.
• W2917729279 hasConceptScore W2917729279C2777453003 @default.
• W2917729279 hasConceptScore W2917729279C2777575956 @default.
• W2917729279 hasConceptScore W2917729279C2779384505 @default.
• W2917729279 hasConceptScore W2917729279C2780132546 @default.
• W2917729279 hasConceptScore W2917729279C2780221984 @default.
• W2917729279 hasConceptScore W2917729279C2780586474 @default.
• W2917729279 hasConceptScore W2917729279C71924100 @default.
• W2917729279 hasIssue "1" @default.
• W2917729279 hasLocation W29177292791 @default.
• W2917729279 hasLocation W29177292792 @default.
• W2917729279 hasLocation W29177292793 @default.
• W2917729279 hasLocation W29177292794 @default.
• W2917729279 hasLocation W29177292795 @default.
• W2917729279 hasOpenAccess W2917729279 @default.
• W2917729279 hasPrimaryLocation W29177292791 @default.
• W2917729279 hasRelatedWork W1588288904 @default.
• W2917729279 hasRelatedWork W2075153701 @default.
• W2917729279 hasRelatedWork W2116752853 @default.
• W2917729279 hasRelatedWork W2162495586 @default.
• W2917729279 hasRelatedWork W2236197927 @default.
• W2917729279 hasRelatedWork W2318799791 @default.
• W2917729279 hasRelatedWork W2755604283 @default.

• next